Abstract

BackgroundNephrectomy is the management of choice for the treatment of renal tumors. Surgical pathologists primarily focus on tumor diagnosis and investigations relating to prognosis or therapy. Pathological changes in non-neoplastic tissue may, however, be relevant for further management and should be thoroughly assessed.MethodsHere, we examined the non-neoplastic renal parenchyma in 206 tumor nephrectomy specimens for the presence of glomerular, tubulo-interstitial, or vascular lesions, and correlated them with clinical parameters and outcome of renal function.ResultsWe analyzed 188 malignant and 18 benign or pseudo-tumorous lesions. The most common tumor type was clear cell renal cell carcinoma (CCRCC, n = 106) followed by papillary or urothelial carcinomas (n = 25). Renal pathology examination revealed the presence of kidney disease in 39 cases (18.9%). Glomerulonephritis was found in 15 cases (7.3%), and the most frequent was IgA nephropathy (n = 6; 2.9%). Vasculitis was found in two cases (0.9%). In 15 cases we found tubulo-interstitial nephritis, and in 9 severe diabetic or hypertensive nephropathy. Partial nephrectomy was not linked to better eGFR at follow-up. Age, vascular nephropathy, glomerular scarring and interstitial fibrosis were the leading independent negative factors influencing eGFR at time of surgery, whereas proteinuria was associated with reduced eGFR at 1 year.ConclusionOur large study population indicates a high incidence of renal diseases potentially relevant for the postoperative management of patients with renal neoplasia. Consistent and systematic reporting of non-neoplastic renal pathology in tumor nephrectomy specimens should therefore be mandatory.

Highlights

  • According to the European Cancer Information System, kidney cancer was the seventh most common and eighth most lethal cancer type in Europe in 2018 [1]

  • Glomerulonephritis was associated with less arteriosclerosis (1 (1–2) vs. 1 (0–2), p = 0.04), but was not associated with age, degree of mesangial expansion, glomerular sclerosis or any of the other histologic lesions we studied of our histologic lesions

  • Studies on the pathology of non-neoplastic kidney diseases in tumor nephrectomy specimens are scarce in European populations, and the size of the cohort studied is comparable to the largest ones from other continents [6,7,8]

Read more

Summary

Introduction

According to the European Cancer Information System, kidney cancer was the seventh most common and eighth most lethal cancer type in Europe in 2018 [1]. Tumor removal leads to nephron loss, reduced kidney function, and compensatory augmentation of filtration in the remaining nephrons. This promotes progressive loss of kidney function and chronic kidney disease (CKD) [2, 3]. Nephrectomy is the management of choice for the treatment of renal tumors. Methods Here, we examined the non-neoplastic renal parenchyma in 206 tumor nephrectomy specimens for the presence of glomerular, tubulo-interstitial, or vascular lesions, and correlated them with clinical parameters and outcome of renal function. Renal pathology examination revealed the presence of kidney disease in 39 cases (18.9%). Consistent and systematic reporting of non-neoplastic renal pathology in tumor nephrectomy specimens should be mandatory

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call